Lilly hid Zyprexa dangers, encouraged off-label promotion: NY Times
Eli Lilly encouraged off-label promotion of its blockbuster drug Zyprexa, while engaging in a decade-long effort to downplay the drug’s ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.